Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes The TAO Randomized Clinical Trial


Steg P. G. , Mehta S. R. , Pollack C. V. , Bode C., Cohen M., French W. J. , ...Daha Fazla

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.310, ss.1145-1155, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 310 Konu: 11
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1001/jama.2013.277165
  • Dergi Adı: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
  • Sayfa Sayıları: ss.1145-1155

Özet

IMPORTANCE The optimal anticoagulant for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) managed with an invasive strategy remains controversial.